3:20 - 3:40pm
Symposium

Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immune and metabolic networks

Session 3

David Michonneau
First International THEMA Leukemia Symposium
3:20 - 3:40pm
    Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot
    Open to all, subject to availability
    -

    Speaker(s)

    David Michonneau

    Events

    Opening speech
    Hugues de Thé, Lise Alter & Matthieu Resche-Rigon

    Symposium
    9:00 - 9:30am
    Not recorded

    Therapy Response and Resistance of AML Stem Cells to Venetoclax
    Andreas Trumpp

    Symposium
    9:30 - 9:50am

    Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
    Andrew Lane

    Symposium
    10:00 - 10:20am

    Overcoming Therapy Resistance in Acute Myeloid Leukemia
    Alexandre Puissant

    Symposium
    10:30 - 10:50am

    Regulation of Hematopoietic Stem Cell Dormancy
    Nina Cabezas

    Symposium
    11:10 - 11:40am

    Unmasking Myeloproliferative Neoplasms Transformation Paths
    Lina Benajiba

    Symposium
    11:40am - 12:00pm

    AML State-Switched
    Clemens Schmitt

    Symposium
    12:05 - 12:30pm
    Not recorded

    Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML
    Marc Raaijmakers

    Symposium
    2:30 - 2:55pm

    Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia
    Diana Passaro

    Symposium
    2:55 - 3:20pm
    Not recorded

    Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
    David Michonneau

    Symposium
    3:20 - 3:40pm

    Quality of Life Matters: A patient perspective
    Emmanuel Raffoux

    Symposium
    4:00 - 4:20pm

    AML Therapy in 2024: increasingly individualized approaches
    Courtney DiNardo

    Symposium
    4:20 - 4:45pm

    VEXAS Syndrome in 2024
    Olivier Kosmider

    Symposium
    4:45 - 5:05pm

    Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
    Régis Peffault de Latour

    Symposium
    5:05 - 5:30pm

    Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
    Lars Velten

    Symposium
    9:00 - 9:25am

    Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
    Emmanuelle Clappier

    Symposium
    9:25 - 9:50am

    From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
    Guillaume Andrieu

    Symposium
    9:50 - 10:15am

    Developmental Origins of Childhood Leukemia: why does it matter?
    Anindita Roy

    Symposium
    10:15 - 10:40am

    AML: Lessons from the Genome
    Timothy Ley

    Symposium
    11:00 - 11:25am
    Not recorded

    Targeting Evil Enhancers and Genes in AML
    Ruud Delwel

    Symposium
    11:25 - 11:50am

    Targeting Cystine Import in AML
    Raphael Itzykson

    Symposium
    11:50am - 12:20pm

    Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
    Keisuke Ito

    Symposium
    1:50 - 2:15pm

    Targeting Microenvironmental Drivers of Blood Malignancies
    Bethan Psaila

    Symposium
    2:15 - 2:40pm
    Not recorded

    Any Crosstalk in the Treatment of AML and HR-MDS
    Lionel Adès

    Symposium
    2:40 - 3:10pm

    Clonal Evolution of Genetic Predisposition to Hematological Malignancies
    Marie Sebert

    Symposium
    3:30 - 3:50pm

    PML Unravels New Insights into the Bases of AML Chemotherapy Response
    Domitille Rérolle

    Symposium
    3:50 - 4:15pm

    Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation
    Paresh Vyas

    Symposium
    4:15 - 4:40pm

    See also

    Hugues de Thé, chair Cellular and Molecular Oncology
    First International THEMA Leukemia Symposium